A Study to Test the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler in People With Chronic Obstructive Pulmonary Disease (COPD) Who Have Different Abilities to Inhale
Clinical trial NCT04223843 · COMPLETED
Trial details
- NCT number
- NCT04223843
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-08
- Primary completion
- 2020-09-07
- Enrollment
- 213
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.